PharmaCyte Biotech, Inc. — All Filings
460 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
10KSB
10KSB/A
10QSB
10QSB/A
3
4
424B2
424B3
424B5
425
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DFAN14A
EFFECT
NT 10-K
NT 10-Q
NTN 10K
NTN 10Q
PRE 14A
PREC14A
S-3
S-3/A
S-3MEF
S-8
S-8 POS
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-I
SC TO-I/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | — | 0001683168-24-004915 | Jul 17, 2024 | Apr 30, 2024 |
| 4 | — | 0001683168-24-004916 | Jul 17, 2024 | Apr 30, 2024 |
| 4 | — | 0001683168-24-004917 | Jul 17, 2024 | Apr 30, 2024 |
| 3 | — | 0001683168-24-003882 | May 30, 2024 | May 23, 2024 |
| SC 13D | SCHEDULE 13D | 0001683168-24-003883 | May 30, 2024 | — |
| 8-K | FORM 8-K | 0001683168-24-003796 | May 23, 2024 | May 20, 2024 |
| 8-K | FORM 8-K | 0001683168-24-002881 | May 1, 2024 | Apr 29, 2024 |
| ARS | ANNUAL REPORT | 0001683168-24-001761 | Mar 27, 2024 | Dec 31, 2023 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001683168-24-001762 | Mar 27, 2024 | Apr 29, 2024 |
| 10-Q | FORM 10-Q FOR JAN 2024 | 0001683168-24-001525 | Mar 18, 2024 | Jan 31, 2024 |
| SC 13G | — | 0001493152-24-006568 | Feb 14, 2024 | — |
| SC 13G/A | AMENDMENT NO. 3 TO SCHEDULE 13G | 0001213900-24-010294 | Feb 6, 2024 | — |
| 10-Q | FORM 10-Q FOR OCTOBER 2023 | 0001683168-23-008889 | Dec 15, 2023 | Oct 31, 2023 |
| 3 | — | 0001683168-23-008503 | Nov 28, 2023 | Nov 21, 2023 |
| 8-K | FORM 8-K | 0001683168-23-008446 | Nov 24, 2023 | Nov 20, 2023 |
| 4 | — | 0001683168-23-008430 | Nov 22, 2023 | Nov 20, 2023 |
| 4 | — | 0001683168-23-008431 | Nov 22, 2023 | Nov 20, 2023 |
| 4 | — | 0001683168-23-008432 | Nov 22, 2023 | Nov 20, 2023 |
| 4 | — | 0001683168-23-008433 | Nov 22, 2023 | Nov 20, 2023 |
| SC 13D | FORM SC-13D | 0001683168-23-008419 | Nov 22, 2023 | — |
| 4 | — | 0001683168-23-008434 | Nov 22, 2023 | Nov 20, 2023 |
| 4 | — | 0001683168-23-008429 | Nov 22, 2023 | Nov 20, 2023 |
| 8-K | CURRENT REPORT | 0001683168-23-008204 | Nov 16, 2023 | Nov 14, 2023 |
| 8-K | CURRENT REPORT | 0001683168-23-007830 | Nov 9, 2023 | Nov 5, 2023 |
| EFFECT | — | 9999999995-23-002857 | Sep 29, 2023 | — |
| CORRESP | — | 0001683168-23-006761 | Sep 27, 2023 | — |
| S-3/A | S-3/A | 0001683168-23-006602 | Sep 21, 2023 | — |
| 10-Q | FORM 10-Q | 0001683168-23-006505 | Sep 18, 2023 | Jul 31, 2023 |
| NT 10-Q | FORM 12B-25 | 0001683168-23-006491 | Sep 15, 2023 | Jul 31, 2023 |
| S-3/A | AMENDMENT 2 | 0001683168-23-006374 | Sep 12, 2023 | — |
| 8-K | FORM 8-K | 0001683168-23-006331 | Sep 7, 2023 | Aug 31, 2023 |
| CORRESP | — | 0001683168-23-005301 | Aug 4, 2023 | — |
| 8-K | FORM 8-K | 0001683168-23-005293 | Aug 4, 2023 | Aug 1, 2023 |
| S-3/A | AMENDMENT NO. 1 | 0001683168-23-005299 | Aug 4, 2023 | — |
| 10-K | ANNUAL REPORT | 0001683168-23-005175 | Jul 31, 2023 | Apr 30, 2023 |
| DEF 14A | DEFINITIVE PROXY | 0001683168-23-005167 | Jul 31, 2023 | Aug 31, 2023 |
| 8-K | CURRENT REPORT | 0001683168-23-004985 | Jul 19, 2023 | Jul 14, 2023 |
| PRE 14A | PRELIMINARY PROXY STATEMENT | 0001683168-23-004986 | Jul 19, 2023 | Aug 31, 2023 |
| UPLOAD | — | 0000000000-23-006796 | Jun 26, 2023 | — |
| SC 13D/A | — | 0000921895-23-001535 | Jun 16, 2023 | — |
| SC TO-I/A | SC TO-I/A | 0001683168-23-004178 | Jun 15, 2023 | — |
| S-3 | REGISTRATION STATEMENT | 0001683168-23-004053 | Jun 9, 2023 | — |
| DEF 14A | DEF 14A | 0001683168-23-003905 | Jun 5, 2023 | — |
| CORRESP | — | 0001683168-23-003902 | Jun 5, 2023 | — |
| CORRESP | — | 0001683168-23-003744 | May 30, 2023 | — |
| PRE 14A | PRELIMINARY PROXY STATEMENT | 0001683168-23-003706 | May 25, 2023 | Jul 7, 2023 |
| UPLOAD | — | 0000000000-23-005380 | May 19, 2023 | — |
| SC 13G | — | 0001493152-23-018409 | May 19, 2023 | — |
| SC 13D/A | AMENDMENT NO. 4 TO THE SCHEDULE 13D | 0000921895-23-001173 | May 12, 2023 | — |
| SC TO-I | SCHEDULE TO-I | 0001683168-23-003170 | May 11, 2023 | — |